Company Profile
Aethlon Medical Stock Price, News & Analysis
Company overview
Business overview
Aethlon Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Aethlon Medical is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Business Model Characteristics
Aethlon Medical makes its case through product adoption, operating discipline, and the pace at which the installed base turns into recurring revenue.
Position Within the Biotechnology Landscape
Compared with drug-development peers, Aethlon Medical trades more like a product-adoption story, where reimbursement, procedure volume, and refresh cycles matter more than a single clinical binary.
Why the stock is moving
AEMD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Aethlon is still very much about the Hemopurifier. The Australian oncology trial, the breakthrough device designation, and the work on infectious disease applications are the things that matter because they tell us whether the device can keep moving toward something more than a single experimental concept.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
Source: Aethlon Medical
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.